SeaStar Medical Holding Corporation, a commercial-stage healthcare company focused on treatments for critically ill patients, announced the pricing of a public offering. The company plans to offer 6,153,847 shares of its common stock and accompanying Series A and Series B warrants at a combined price of $0.65 per share. The offering is expected to generate approximately $4 million in gross proceeds initially, with the potential for an additional $4 million if the Series B short-term warrants are fully exercised. H.C. Wainwright & Co. is serving as the exclusive placement agent for this offering. The proceeds will be used for general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.